KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Non-Current Receivables (2018 - 2020)

Evolent Health has reported Non-Current Receivables over the past 3 years, most recently at $860000.0 for Q1 2020.

  • For Q1 2020, Non-Current Receivables fell 49.26% year-over-year to $860000.0; the TTM value through Mar 2020 reached $860000.0, down 49.26%, while the annual FY2019 figure was $999000.0, 3.95% up from the prior year.
  • Non-Current Receivables for Q1 2020 was $860000.0 at Evolent Health, down from $999000.0 in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $1.7 million in Q1 2019 and troughed at $860000.0 in Q1 2020.
  • A 3-year average of $1.2 million and a median of $1.2 million in 2019 define the central range for Non-Current Receivables.
  • Biggest five-year swings in Non-Current Receivables: grew 24.5% in 2019 and later tumbled 49.26% in 2020.
  • Year by year, Non-Current Receivables stood at $961000.0 in 2018, then grew by 3.95% to $999000.0 in 2019, then decreased by 13.91% to $860000.0 in 2020.
  • Business Quant data shows Non-Current Receivables for EVH at $860000.0 in Q1 2020, $999000.0 in Q4 2019, and $1.2 million in Q3 2019.